|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.255 USD | +2.42% |
|
+11.56% | +14.80% |
| 06-09 | Cartesian Therapeutics Signs Licensing Agreement With WestGene to Develop Therapies for Autoimmune Diseases | MT |
| 05-26 | Cartesian Therapeutics, Inc. Announces Executive Changes | CI |
| Market Cap | 237M 205M 191M 176M 332M 22.52B 336M 2.25B 882M 11.27B 889M 870M 37.31B | P/E 2026 * |
-1.94x | P/E 2027 * | -2.11x |
|---|---|---|---|---|---|
| Enterprise Value | 93.32M 80.82M 75.34M 69.29M 131M 8.87B 132M 885M 347M 4.44B 350M 343M 14.7B | EV / Sales 2026 * |
169x | EV / Sales 2027 * | -163x |
| Free-Float |
46.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cartesian Therapeutics, Inc.
| 1 day | +2.48% | ||
| 1 week | +11.56% | ||
| Current month | +6.12% | ||
| 1 month | -19.95% | ||
| 3 months | +12.01% | ||
| 6 months | +31.81% | ||
| Current year | +14.80% |
| 1 week | 7.31 |  | 8.61 |
| 1 month | 7.27 | | 10.84 |
| Current year | 5.6 | | 11 |
| 1 year | 5.6 | | 12.25 |
| 3 years | 5.6 | | 42.6 |
| 5 years | 5.6 | | 42.6 |
| 10 years | 5.6 | | 42.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/6/26 A | Sell | Chief Technology Officer | 3,573 | 0.0137% | ||
| 1/6/26 A | Sell | Chief Executive Officer | 23,766 | 0.0914% | ||
| 1/6/26 A | Sell | Chief Financial Officer | 10,591 | 0.0407% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.42% | +11.56% | -30.03% | - | 237M | |
| +4.35% | +19.90% | +60.59% | +95.21% | 62.53B | |
| +2.83% | -3.48% | +24.97% | +69.33% | 52.43B | |
| +1.13% | -0.89% | -17.06% | -6.48% | 23.1B | |
| +0.96% | -3.08% | -10.46% | +356.97% | 21.4B | |
| +0.40% | +5.29% | +30.11% | -9.63% | 21.17B | |
| +0.75% | +1.34% | +32.22% | -25.54% | 17.76B | |
| +9.88% | +19.73% | +229.67% | +385.49% | 15.47B | |
| +2.08% | -3.28% | +21.67% | +564.59% | 14.68B | |
| +1.16% | +2.15% | +50.88% | +179.11% | 14.08B | |
| Average | +2.60% | +3.82% | +39.26% | +178.78% | 24.29B | |
| Weighted average by Cap. | +2.84% | +4.59% | +42.28% | +136.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 552K 478K 446K 410K 774K 52.51M 783K 5.24M 2.06M 26.27M 2.07M 2.03M 87.02M | 402K 348K 324K 298K 563K 38.18M 569K 3.81M 1.5M 19.1M 1.51M 1.47M 63.26M |
| Net income | -122M -106M -98.78M -90.85M -172M -11.63B -173M -1.16B -456M -5.82B -460M -449M -19.28B | -131M -113M -106M -97.07M -183M -12.43B -185M -1.24B -487M -6.22B -491M -480M -20.6B |
| Net Debt | -144M -124M -116M -107M -201M -13.64B -203M -1.36B -534M -6.83B -539M -527M -22.61B | -302M -262M -244M -224M -423M -28.73B -428M -2.87B -1.12B -14.37B -1.13B -1.11B -47.6B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | $8.270 | +2.61% | 71,573 |
| 04/08/26 | $8.060 | +2.41% | 297,963 |
| 03/08/26 | $7.870 | +0.90% | 111,947 |
| 31/07/26 | $7.800 | +0.91% | 140,249 |
| 30/07/26 | $7.730 | +4.18% | 98,714 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNAC Stock
Select your edition
All financial news and data tailored to specific country editions
